Melatonin as an Agent for Cardioprotection in Patients with ST-Elevation Myocardial Infarction and Short Ischaemic Time

Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez; Russel J. Reiter

doi:10.1007/s10557-016-6708-8

Melatonin as an Agent for Cardioprotection in Patients with ST-Elevation Myocardial Infarction and Short Ischaemic Time

Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Russel J. Reiter

Department of Cell Systems & Anatomy

Producción científica: Editorial › revisión exhaustiva

3 Citas (Scopus)

Idioma original	English (US)
Páginas (desde-hasta)	227-228
Número de páginas	2
Publicación	Cardiovascular Drugs and Therapy
Volumen	31
N.º	2
DOI	https://doi.org/10.1007/s10557-016-6708-8
Estado	Published - abr 1 2017

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Pharmacology (medical)
Pharmacology

Acceder al documento

10.1007/s10557-016-6708-8

Otros archivos y enlaces

Citar esto

@article{7d007b637839475faea1cdef05ced50c,

title = "Melatonin as an Agent for Cardioprotection in Patients with ST-Elevation Myocardial Infarction and Short Ischaemic Time",

author = "Alberto Dominguez-Rodriguez and Pedro Abreu-Gonzalez and Reiter, {Russel J.}",

note = "Funding Information: Funding This editorial was supported by Institute Carlos III (ISCIII) (PI15 / 01260), General Branch Evaluation and Research Promotion, State Plan of Scientific and Technical Research and Innovation 2013– 2016 and European Regional Development Fund Health - FEDER-, which relates to the topic of this study.",

year = "2017",

month = apr,

day = "1",

doi = "10.1007/s10557-016-6708-8",

language = "English (US)",

volume = "31",

pages = "227--228",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - Melatonin as an Agent for Cardioprotection in Patients with ST-Elevation Myocardial Infarction and Short Ischaemic Time

AU - Dominguez-Rodriguez, Alberto

AU - Abreu-Gonzalez, Pedro

AU - Reiter, Russel J.

N1 - Funding Information: Funding This editorial was supported by Institute Carlos III (ISCIII) (PI15 / 01260), General Branch Evaluation and Research Promotion, State Plan of Scientific and Technical Research and Innovation 2013– 2016 and European Regional Development Fund Health - FEDER-, which relates to the topic of this study.

PY - 2017/4/1

Y1 - 2017/4/1

UR - http://www.scopus.com/inward/record.url?scp=85018821832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018821832&partnerID=8YFLogxK

U2 - 10.1007/s10557-016-6708-8

DO - 10.1007/s10557-016-6708-8

M3 - Editorial

C2 - 28101742

AN - SCOPUS:85018821832

SN - 0920-3206

VL - 31

SP - 227

EP - 228

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

IS - 2

ER -